CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries
CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews
CHAPTER NO. 3 : SHORT BOWEL SYNDROME MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Drug Frontiers – Lucrative Drug Categories
4.3 Distribution Channel Sweet Spots – Emerging Demand Segments
CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Drug, Patient Age Group, and Distribution Channel Revenue
CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis By Region
6.1.1. Global Short Bowel Syndrome Market Import Revenue By Region
6.2. Export Analysis By Region
6.2.1. Global Short Bowel Syndrome Market Export Revenue By Region
CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Short Bowel Syndrome Market: Company Market Share
7.2. Global Short Bowel Syndrome Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Drug Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024
CHAPTER NO. 8 : SHORT BOWEL SYNDROME MARKET – BY DRUG SEGMENT ANALYSIS
8.1. Short Bowel Syndrome Market Overview By Drug Segment
8.1.1. Short Bowel Syndrome Market Revenue Share By Drug
8.2. GLP-2
8.3. Glutamine
8.4. Growth Hormones
8.5. Other Drugs
CHAPTER NO. 9 : SHORT BOWEL SYNDROME MARKET – BY PATIENT AGE GROUP SEGMENT ANALYSIS
9.1. Short Bowel Syndrome Market Overview By Patient Age Group Segment
9.1.1. Short Bowel Syndrome Market Revenue Share By Patient Age Group
9.2. Adult (>18)
9.3. Pediatric (<18)
CHAPTER NO. 10 : SHORT BOWEL SYNDROME MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS
10.1. Short Bowel Syndrome Market Overview By Distribution Channel Segment
10.1.1. Short Bowel Syndrome Market Revenue Share By Distribution Channel
10.2. Hospital Pharmacies
10.3. Retail Pharmacies
10.4. Other Pharmacies
CHAPTER NO. 11 : SHORT BOWEL SYNDROME MARKET – REGIONAL ANALYSIS
11.1. Short Bowel Syndrome Market Overview By Region Segment
11.1.1. Global Short Bowel Syndrome Market Revenue Share By Region
10.1.2. Regions
11.1.3. Global Short Bowel Syndrome Market Revenue By Region
11.1.4. Drug
11.1.5. Global Short Bowel Syndrome Market Revenue By Drug
11.1.6. Patient Age Group
11.1.7. Global Short Bowel Syndrome Market Revenue By Patient Age Group
11.1.8. Distribution Channel
11.1.9. Global Short Bowel Syndrome Market Revenue By Distribution Channel
CHAPTER NO. 12 : NORTH AMERICA SHORT BOWEL SYNDROME MARKET – COUNTRY ANALYSIS
12.1. North America Short Bowel Syndrome Market Overview By Country Segment
12.1.1. North America Short Bowel Syndrome Market Revenue Share By Region
12.2. North America
12.2.1. North America Short Bowel Syndrome Market Revenue By Country
12.2.2. Drug
12.2.3. North America Short Bowel Syndrome Market Revenue By Drug
12.2.4. Patient Age Group
12.2.5. North America Short Bowel Syndrome Market Revenue By Patient Age Group
12.2.6. Distribution Channel
12.2.7. North America Short Bowel Syndrome Market Revenue By Distribution Channel
12.3. U.S.
12.4. Canada
12.5. Mexico
CHAPTER NO. 13 : EUROPE SHORT BOWEL SYNDROME MARKET – COUNTRY ANALYSIS
13.1. Europe Short Bowel Syndrome Market Overview By Country Segment
13.1.1. Europe Short Bowel Syndrome Market Revenue Share By Region
13.2. Europe
13.2.1. Europe Short Bowel Syndrome Market Revenue By Country
13.2.2. Drug
13.2.3. Europe Short Bowel Syndrome Market Revenue By Drug
13.2.4. Patient Age Group
13.2.5. Europe Short Bowel Syndrome Market Revenue By Patient Age Group
13.2.6. Distribution Channel
13.2.7. Europe Short Bowel Syndrome Market Revenue By Distribution Channel
13.3. UK
13.4. France
13.5. Germany
13.6. Italy
13.7. Spain
13.8. Russia
13.9. Rest of Europe
CHAPTER NO. 14 : ASIA PACIFIC SHORT BOWEL SYNDROME MARKET – COUNTRY ANALYSIS
14.1. Asia Pacific Short Bowel Syndrome Market Overview By Country Segment
14.1.1. Asia Pacific Short Bowel Syndrome Market Revenue Share By Region
14.2. Asia Pacific
14.2.1. Asia Pacific Short Bowel Syndrome Market Revenue By Country
14.2.2. Drug
14.2.3. Asia Pacific Short Bowel Syndrome Market Revenue By Drug
14.2.4. Patient Age Group
14.2.5. Asia Pacific Short Bowel Syndrome Market Revenue By Patient Age Group
14.2.6. Distribution Channel
14.2.7. Asia Pacific Short Bowel Syndrome Market Revenue By Distribution Channel
14.3. China
14.4. Japan
14.5. South Korea
14.6. India
14.7. Australia
14.8. Southeast Asia
14.9. Rest of Asia Pacific
CHAPTER NO. 15 : LATIN AMERICA SHORT BOWEL SYNDROME MARKET – COUNTRY ANALYSIS
15.1. Latin America Short Bowel Syndrome Market Overview By Country Segment
15.1.1. Latin America Short Bowel Syndrome Market Revenue Share By Region
15.2. Latin America
15.2.1. Latin America Short Bowel Syndrome Market Revenue By Country
15.2.2. Drug
15.2.3. Latin America Short Bowel Syndrome Market Revenue By Drug
15.2.4. Patient Age Group
15.2.5. Latin America Short Bowel Syndrome Market Revenue By Patient Age Group
15.2.6. Distribution Channel
15.2.7. Latin America Short Bowel Syndrome Market Revenue By Distribution Channel
15.3. Brazil
15.4. Argentina
15.5. Rest of Latin America
CHAPTER NO. 16 : MIDDLE EAST SHORT BOWEL SYNDROME MARKET – COUNTRY ANALYSIS
16.1. Middle East Short Bowel Syndrome Market Overview By Country Segment
16.1.1. Middle East Short Bowel Syndrome Market Revenue Share By Region
16.2. Middle East
16.2.1. Middle East Short Bowel Syndrome Market Revenue By Country
16.2.2. Drug
16.2.3. Middle East Short Bowel Syndrome Market Revenue By Drug
16.2.4. Patient Age Group
16.2.5. Middle East Short Bowel Syndrome Market Revenue By Patient Age Group
16.2.6. Distribution Channel
16.2.7. Middle East Short Bowel Syndrome Market Revenue By Distribution Channel
16.3. GCC Countries
16.4. Israel
16.5. Turkey
16.6. Rest of Middle East
CHAPTER NO. 17 : AFRICA SHORT BOWEL SYNDROME MARKET – COUNTRY ANALYSIS
17.1. Africa Short Bowel Syndrome Market Overview By Country Segment
17.1.1. Africa Short Bowel Syndrome Market Revenue Share By Region
17.2. Africa
17.2.1. Africa Short Bowel Syndrome Market Revenue By Country
17.2.2. Drug
17.2.3. Africa Short Bowel Syndrome Market Revenue By Drug
17.2.4. Patient Age Group
17.2.5. Africa Short Bowel Syndrome Market Revenue By Patient Age Group
17.2.6. Distribution Channel
17.2.7. Africa Short Bowel Syndrome Market Revenue By Distribution Channel
17.3. South Africa
17.4. Egypt
17.5. Rest of Africa
CHAPTER NO. 18 : COMPANY PROFILES
18.1. Takeda Pharmaceutical Co. Ltd.
18.1.1. Company Overview
18.1.2. Drug Portfolio
18.1.3. Financial Overview
18.1.4. Recent Developments
18.1.5. Growth Strategy
18.1.6. SWOT Analysis
18.2. Merck KGaA
18.3. Ironwood Pharmaceuticals
18.4. OxThera AB
18.5. Nutrinia Ltd.
18.6. Nestlé Health Science
18.7. Hanmi Pharmaceutical
18.8. Zealand Pharma A/S
18.9. Shire plc
18.10. Sancilio & Company, Inc.
18.11. Naia Pharmaceuticals, Inc.
18.12. Other Key Players